309 related articles for article (PubMed ID: 16302009)
21. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
22. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
[TBL] [Abstract][Full Text] [Related]
23. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
[TBL] [Abstract][Full Text] [Related]
24. Genetic association of low density lipoprotein receptor and Alzheimer's disease.
Gopalraj RK; Zhu H; Kelly JF; Mendiondo M; Pulliam JF; Bennett DA; Estus S
Neurobiol Aging; 2005 Jan; 26(1):1-7. PubMed ID: 15585340
[TBL] [Abstract][Full Text] [Related]
25. Family-based association between Alzheimer's disease and variants in UBQLN1.
Bertram L; Hiltunen M; Parkinson M; Ingelsson M; Lange C; Ramasamy K; Mullin K; Menon R; Sampson AJ; Hsiao MY; Elliott KJ; Velicelebi G; Moscarillo T; Hyman BT; Wagner SL; Becker KD; Blacker D; Tanzi RE
N Engl J Med; 2005 Mar; 352(9):884-94. PubMed ID: 15745979
[TBL] [Abstract][Full Text] [Related]
26. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
27. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease.
Chen Y; Jia L; Wei C; Wang F; Lv H; Jia J
Brain Res; 2008 Oct; 1233():196-202. PubMed ID: 18671953
[TBL] [Abstract][Full Text] [Related]
28. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
29. Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.
Feuk L; Prince JA; Blennow K; Brookes AJ
Hum Mutat; 2003 Jan; 21(1):53-60. PubMed ID: 12497631
[TBL] [Abstract][Full Text] [Related]
30. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
[TBL] [Abstract][Full Text] [Related]
31. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
[TBL] [Abstract][Full Text] [Related]
32. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
Helisalmi S; Väkevä A; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
[TBL] [Abstract][Full Text] [Related]
33. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
Björk BF; Katzov H; Kehoe P; Fratiglioni L; Winblad B; Prince JA; Graff C
Neurobiol Aging; 2007 Sep; 28(9):1374-80. PubMed ID: 16876916
[TBL] [Abstract][Full Text] [Related]
34. Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.
Mueller JC; Riemenschneider M; Schoepfer-Wendels A; Gohlke H; Konta L; Friedrich P; Illig T; Laws SM; Förstl H; Kurz A
Neurobiol Aging; 2007 May; 28(5):727-34. PubMed ID: 16675064
[TBL] [Abstract][Full Text] [Related]
35. Association of SORL1 gene variants with Alzheimer's disease.
Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Teipel SJ; Kornhuber J; Frölich L; Heuser I; Peters O; Wiese B; Kaduszkiewicz H; van den Bussche H; Hüll M; Kurz A; Rüther E; Henn FA; Maier W
Brain Res; 2009 Apr; 1264():1-6. PubMed ID: 19368828
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of multiple presenilin 2 SNPs for association with early-onset sporadic Alzheimer disease.
Howell WM; Brookes AJ
Am J Med Genet; 2002 Aug; 111(2):157-63. PubMed ID: 12210343
[TBL] [Abstract][Full Text] [Related]
37. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
[TBL] [Abstract][Full Text] [Related]
38. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
39. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
[TBL] [Abstract][Full Text] [Related]
40. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
